CIENCIASMEDICASNEWS: CDC's Grand Rounds Presents “The Growing Threat of Multidrug-Resistant Gonorrhea” on Tuesday, May 15 (1 p.m. EDT)

martes, 8 de mayo de 2012

CDC's Grand Rounds Presents “The Growing Threat of Multidrug-Resistant Gonorrhea” on Tuesday, May 15 (1 p.m. EDT)

CDC - Grand Rounds
Main Entry Page - Online Registration and Accreditation (TCEOnline) - CDC

We are pleased to present the May session of CDC’s Public Health Grand Rounds, “The Growing Threat of Multidrug-Resistant Gonorrhea.” This session will be available via live webcast from CDC headquarters in Atlanta, Georgia on Tuesday, May 15 at 1 p.m. (EDT) at www.cdc.gov/about/grand-rounds.

This session of Grand Rounds will explore the development of antibiotic resistance in Neisseria gonorrhoeae as a growing public health concern because the United States gonorrhea control strategy relies on effective antibiotic therapy. Since antibiotics were first used for treatment of gonorrhea, the organism has progressively developed resistance to the sulfa drugs prescribed to treat it. Currently, CDC STD treatment guidelines recommend dual therapy with a cephalosporin antibiotic (ceftriaxone is preferred) and either azithromycin or doxycycline to treat all uncomplicated gonococcal infections among adults and adolescents in the United States.

Presented By:

Edward Hook III, MD
Professor of Medicine and Epidemiology
University of Alabama, Birmingham
“Neisseria Gonorrhoeae Infections and Antimicrobial Treatment: Public Health Context and Challenges”

William Shafer, PhD
Professor of Microbiology and Immunology
Emory University
“Molecular Basis of Resistance and Importance of the Laboratory in Detection of Resistance”

Carolyn Deal, PhD
Chief, Sexually Transmitted Diseases Branch
National Institute of Allergy and Infectious Diseases
National Institutes of Health
“Tools to Combat Multidrug Resistance”

Robert D. Kirkcaldy, MD, MPH
Medical Officer
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC
“What Public Health Can Do Now and in the Future”

Facilitated By:

Tanja Popovic, MD, PhD, Scientific Director, Public Health Grand Rounds
John Iskander, MD, MPH, Deputy Scientific Director, Public Health Grand Rounds
Susan Laird, MSN, RN, Communications Manager, Public Health Grand Rounds

Grand Rounds is available for Continuing Education.

ALL Continuing Education for PHGR are issued online through the CDC/ATSDR Training & Continuing Education Online system. If you have questions, email or call Learner Support at 1-800-418-7246 (1-800-41TRAIN).

Those who attend PHGR either in person, Envision, IPTV, or “web on demand” and who wish to receive Continuing Education must complete the online seminar evaluation. Thirty days from the initial seminar the course number will change to WD1640 and will be available for continuing education until January 21, 2014. The course code for PHGR is PHGR10.

Target Audience: Physicians, nurses, epidemiologists, pharmacists, veterinarians, certified health education specialists, laboratorians, others

Objectives:

List key measures of burden of disease involving morbidity, mortality, and/or cost.
Describe evidence-based preventive interventions and the status of their implementations.
Identify one key prevention science research gap.
Name one key indicator by which progress and meeting prevention goals is measured.

CE certificates can be printed from your computer immediately upon completion of your online evaluation. A cumulative transcript of all CDC/ATSDR CE’s obtained through the TCE Online System will be maintained for each user. We hope that this will assist CDC staff and other public health professionals to fulfill the requirements for their professional licenses and certificates.

Antibiotic-Resistant Gonorrhea

Collage of people and Neisseria gonorrhoeae.

The emergence of cephalosporin-resistant gonorrhea in the United States would make gonorrhea much more difficult to treat.
Gonorrhea has progressively developed resistance to the antibiotic drugs prescribed to treat it. The emergence of cephalosporin-resistant gonorrhea would significantly complicate our ability to treat gonorrhea successfully, since we have few antibiotic options left that are simple, well-studied, and highly effective. It is critical to continuously monitor antibiotic resistance in Neisseria gonorrhoeae and encourage research and development of new treatment regimens.
View Basic Information »
Data, trends, challenges, and lab information